Saptalis Pharms Drug Patent Portfolio
Saptalis Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Saptalis Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11541035 | Oral formulations of metronidazole and methods of treating an infection using same | 04 Oct, 2039 | Active |
Latest Legal Activities on Saptalis Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Saptalis Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 07 May, 2024 | US11541035 |
| Mail Patent eCofC Notification | 07 May, 2024 | US11541035 |
| Patent eCofC Notification | 07 May, 2024 | US11541035 |
| Recordation of Patent eCertificate of Correction | 07 May, 2024 | US11541035 |
| Mail Certificate of Correction Memo | 17 Apr, 2024 | US11541035 |
| Certificate of Correction Memo | 12 Apr, 2024 | US11541035 |
|
Recordation of Patent Grant Mailed
Critical
| 03 Jan, 2023 | US11541035 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Jan, 2023 | US11541035 |
|
Email Notification
Critical
| 15 Dec, 2022 | US11541035 |
|
Issue Notification Mailed
Critical
| 14 Dec, 2022 | US11541035 |
|
Application Is Considered Ready for Issue
Critical
| 05 Dec, 2022 | US11541035 |
| Dispatch to FDC | 05 Dec, 2022 | US11541035 |
|
Issue Fee Payment Received
Critical
| 30 Nov, 2022 | US11541035 |
|
Issue Fee Payment Verified
Critical
| 30 Nov, 2022 | US11541035 |
|
Electronic Review
Critical
| 02 Sep, 2022 | US11541035 |
Saptalis Pharms's Family Patents
Saptalis Pharms Drug List
Given below is the complete list of Saptalis Pharms's drugs and the patents protecting them.
1. Likmez
Likmez is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11541035 | Oral formulations of metronidazole and methods of treating an infection using same |
04 Oct, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Likmez's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List